Skip to main content

Table 5 Mean values and frequency of altered lipid profile

From: Apolipoprotein E and plasminogen activator inhibitor 1 gene polymorphism in children with chronic renal insufficiency associated with cardiovascular disease

Group

Parameter

Mean

ST.D

Min

Max

P value

Significant

Frequency (%)

GR1

Triglycerides (T.G)

200.5

112.03

59.0

366.0

0.034

Sig

46

GR2

177.75

84.46

66.0

428.0

GR3

107.40

51.12

45.0

203.0

GR1

Total cholesterol (CHO)

177.6

41.07

135.5

273.0

0.569

N.S

28

GR2

167.0

36.96

112.0

267.0

GR3

183.6

57.21

114.0

282.0

GR1

High-density lipoprotein (HDL)

42.40

8.03

29.00

52.0

0.247

N.S

20

GR2

46.35

5.48

31.00

56.0

GR3

48.00

16.56

34.00

85.0

GR1

Low-density lipoprotein (LDL)

96.80

3.05

71.0

198.0

0.496

N.S

44

GR2

87.15

42.65

28.0

179.0

GR3

114.10

42.90

69.0

204.0

GR1

CHO/HDL

4.54

1.87

2.9

8.3

0.625

N.S

16

GR2

3.61

0.95

2.3

6.4

GR3

4.00

1.40

2.7

7.6